Towards Eradication: Reducing Proviral HIV DNA With Interferon-a Immunotherapy
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 10 Apr 2018
At a glance
- Drugs Peginterferon alfa-2b (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- Acronyms BEAT-HIV
- 03 Apr 2018 Planned End Date changed from 1 Aug 2018 to 24 Jul 2018.
- 08 Sep 2017 Status changed from recruiting to active, no longer recruiting.
- 10 Jun 2017 Biomarkers information updated